
HANOI -- Vietnam's domestically developed coronavirus vaccine candidate has begun Phase 3 clinical trials, with the country hoping to package doses for market by the end of the year.
Doses enter Phase 3 trials, but Hanoi could approve emergency use as cases climb
HANOI -- Vietnam's domestically developed coronavirus vaccine candidate has begun Phase 3 clinical trials, with the country hoping to package doses for market by the end of the year.
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.